company background image
ACCD logo

Accolade NasdaqGS:ACCD Stock Report

Last Price

US$9.99

Market Cap

US$773.3m

7D

1.6%

1Y

-25.3%

Updated

27 Mar, 2024

Data

Company Financials +

ACCD Stock Overview

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.

ACCD fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Accolade, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Accolade
Historical stock prices
Current Share PriceUS$9.99
52 Week HighUS$17.01
52 Week LowUS$6.33
Beta2.08
1 Month Change-7.07%
3 Month Change-22.26%
1 Year Change-25.28%
3 Year Change-77.98%
5 Year Changen/a
Change since IPO-66.36%

Recent News & Updates

Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Feb 17
Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Accolade: Remain Confident That FY25 Guided Growth Is Achievable

Jan 17

Accolade: Turning Bullish After Beat-And-Raise Quarter (Rating Upgrade)

Jan 11

Recent updates

Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Feb 17
Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price

Accolade: Remain Confident That FY25 Guided Growth Is Achievable

Jan 17

Accolade: Turning Bullish After Beat-And-Raise Quarter (Rating Upgrade)

Jan 11

Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge

Jun 13
Why Investors Shouldn't Be Surprised By Accolade, Inc.'s (NASDAQ:ACCD) 27% Share Price Surge

Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?

May 02
Is There Now An Opportunity In Accolade, Inc. (NASDAQ:ACCD)?

An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued

Feb 05
An Intrinsic Calculation For Accolade, Inc. (NASDAQ:ACCD) Suggests It's 28% Undervalued

Accolade: Inching Closer To Profitability

Oct 17

Accolade Q2 2023 Earnings Preview

Oct 05

Accolade: Fair And Reasonably Priced, But Needs More Time

Aug 09

Accolade Q1 2023 Earnings Preview

Jun 29

Accolade: Little Recent Applause

Mar 28

Accolade Impresses With Revenue Growth But Faces Operating Losses

Dec 16

Accolade: I May Add To My Position

Oct 18

Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price Targets

Jul 11
Accolade, Inc. (NASDAQ:ACCD) Just Reported And Analysts Have Been Lifting Their Price Targets

Accolade, Inc. 2021 Q4 - Results - Earnings Call Presentation

May 06

Here's Why We're Not Too Worried About Accolade's (NASDAQ:ACCD) Cash Burn Situation

Mar 19
Here's Why We're Not Too Worried About Accolade's (NASDAQ:ACCD) Cash Burn Situation

Is Accolade, Inc. (NASDAQ:ACCD) Popular Amongst Institutions?

Jan 15
Is Accolade, Inc. (NASDAQ:ACCD) Popular Amongst Institutions?

Accolade is up 7% on acquisition of 2nd.MD

Jan 14

Accolade Inc.: Bullish Outlook As Its HealthTech Platform Helps Companies Save

Jan 12

Accolade, Inc. 2021 Q3 - Results - Earnings Call Presentation

Jan 11

Accolade Q3 2021 Earnings Preview

Jan 06

Shareholder Returns

ACCDUS HealthcareUS Market
7D1.6%0.6%0.4%
1Y-25.3%9.5%28.8%

Return vs Industry: ACCD underperformed the US Healthcare industry which returned 8.4% over the past year.

Return vs Market: ACCD underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is ACCD's price volatile compared to industry and market?
ACCD volatility
ACCD Average Weekly Movement11.7%
Healthcare Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: ACCD's share price has been volatile over the past 3 months.

Volatility Over Time: ACCD's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20072,370Raj Singhhttps://www.accolade.com

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. It also provides medical opinion and decision support services; and technology and administrative services to the medical practice PCs providing virtual primary care services.

Accolade, Inc. Fundamentals Summary

How do Accolade's earnings and revenue compare to its market cap?
ACCD fundamental statistics
Market capUS$773.30m
Earnings (TTM)-US$122.73m
Revenue (TTM)US$388.49m

2.0x

P/S Ratio

-6.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACCD income statement (TTM)
RevenueUS$388.49m
Cost of RevenueUS$213.49m
Gross ProfitUS$175.00m
Other ExpensesUS$297.73m
Earnings-US$122.73m

Last Reported Earnings

Nov 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.59
Gross Margin45.05%
Net Profit Margin-31.59%
Debt/Equity Ratio47.9%

How did ACCD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.